VCU researchers receive $4.2M NIH grant to study treatment for chemical attacks

With the backing of a five-year award of approximately $4.2 million in total costs from the National Institutes of Health, Robert DeLorenzo and a team of Virginia Commonwealth University researchers are studying and developing ways to treat and prevent human fatalities and morbidity that could result from chemical attacks on U.S. soil.

DeLorenzo, M.D., Ph.D., the George Bliley Professor of Neurology in the VCU School of Medicine, is the principal investigator on the team that received the grant from the NIH Countermeasures Against Chemical Threats program. CounterACT supports basic and translational research aimed at identifying medical countermeasures against chemical threats.

DeLorenzo said public safety is the key goal behind the research. He is working with Robert Blair, Ph.D. (Ph.D.’98/M), and Laxmikant Deshpande, Ph.D. (Ph.D.’06/M), assistant professors in the VCU School of Medicine Department of Neurology, as well as Rakesh Kukreja, Ph.D., the Eric Lipman Professor of Medicine in the Department of Internal Medicine, and Matthew Halquist, Ph.D., assistant professor and laboratory director in the Department of Pharmaceutics in the School of Pharmacy.